IDEAS home Printed from https://ideas.repec.org/a/spr/eujhec/v20y2019i5d10.1007_s10198-018-1028-5.html
   My bibliography  Save this article

Conflict of interest disclosure: striking a balance?

Author

Listed:
  • Livio Garattini

    (CESAV, Institute for Pharmacological Research Mario Negri IRCCS)

  • Anna Padula

    (CESAV, Institute for Pharmacological Research Mario Negri IRCCS)

Abstract

No abstract is available for this item.

Suggested Citation

  • Livio Garattini & Anna Padula, 2019. "Conflict of interest disclosure: striking a balance?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(5), pages 633-636, July.
    • Handle: RePEc:spr:eujhec:v:20:y:2019:i:5:d:10.1007_s10198-018-1028-5
    DOI: 10.1007/s10198-018-1028-5
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s10198-018-1028-5
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s10198-018-1028-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Cristina Morciano & Vittorio Basevi & Carla Faralli & Michele Hilton Boon & Sabina Tonon & Domenica Taruscio, 2016. "Policies on Conflicts of Interest in Health Care Guideline Development: A Cross-Sectional Analysis," PLOS ONE, Public Library of Science, vol. 11(11), pages 1-24, November.
    2. Lisa A Bero & Quinn Grundy, 2016. "Why Having a (Nonfinancial) Interest Is Not a Conflict of Interest," PLOS Biology, Public Library of Science, vol. 14(12), pages 1-8, December.
    3. Livio Garattini & Anna Padula, 2018. "Patient empowerment in Europe: is no further research needed?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(5), pages 637-640, June.
    4. Livio Garattini & Anna Padula, 2018. "Pharmaceutical pricing conundrum: time to get rid of it?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(8), pages 1035-1038, November.
    5. Powell, Martin & Béland, Daniel & Waddan, Alex, 2018. "The Americanization of the British National Health Service: A typological approach," Health Policy, Elsevier, vol. 122(7), pages 775-782.
    6. Livio Garattini & Anna Padula, 2018. "Competition in pharmaceuticals: more product- than price-oriented?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(1), pages 1-4, January.
    7. Grundy, Quinn & Habibi, Roojin & Shnier, Adrienne & Mayes, Christopher & Lipworth, Wendy, 2018. "Decoding disclosure: Comparing conflict of interest policy among the United States, France, and Australia," Health Policy, Elsevier, vol. 122(5), pages 509-518.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. L. Garattini & Marco Badinella Martini, 2023. "Modeling European health systems: a theoretical exercise," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(8), pages 1249-1252, November.
    2. Livio Garattini & Anna Padula, 2020. "Defensive medicine in Europe: a ‘full circle’?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(4), pages 477-482, June.
    3. Livio Garattini & Anna Padula & Nicholas Freemantle, 2021. "Pricing vaccines and drugs in Europe: worth differentiating?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(9), pages 1345-1348, December.
    4. Livio Garattini & Anna Padula, 2020. "Defensive medicine in Europe: a ‘full circle’?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(2), pages 165-170, March.
    5. Livio Garattini & Anna Padula, 2020. "HTA for pharmaceuticals in Europe: will the mountain deliver a mouse?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(1), pages 1-5, February.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Dobiášová, Karolína & Kotherová, Zuzana & Numerato, Dino, 2021. "Institutional reforms to strengthen patient and public involvement in the Czech Republic since 2014," Health Policy, Elsevier, vol. 125(5), pages 582-586.
    2. Joanne Khabsa & Jennifer Petkovic & Alison Riddle & Lyubov Lytvyn & Olivia Magwood & Pearl Atwere & Pauline Campbell & Srinivasa V. Katikireddi & Bronwen Merner & Mona Nasser & Stephanie Chang & Aleja, 2022. "PROTOCOL: Conflict of interest issues when engaging stakeholders in health and healthcare guideline development: a systematic review," Campbell Systematic Reviews, John Wiley & Sons, vol. 18(2), June.
    3. Shai Mulinari & Andreas Vilhelmsson & Emily Rickard & Piotr Ozieranski, 2020. "Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs," PLOS ONE, Public Library of Science, vol. 15(6), pages 1-19, June.
    4. Rachel Thompson & Zoe Paskins & Barry G. Main & Thaddeus Mason Pope & Evelyn C. Y. Chan & Ben W. Moulton & Michael J. Barry & Clarence H. Braddock III, 2021. "Addressing Conflicts of Interest in Health and Medicine: Current Evidence and Implications for Patient Decision Aid Development," Medical Decision Making, , vol. 41(7), pages 768-779, October.
    5. Elena Druică & Cristian Băicuș & Rodica Ianole-Călin & Ronald Fischer, 2021. "Information or Habit: What Health Policy Makers Should Know about the Drivers of Self-Medication among Romanians," IJERPH, MDPI, vol. 18(2), pages 1-15, January.
    6. Gabor Hetenyi & Magdolna Szilasi & Attila Lengyel, 2019. "PLS Modelling of Factors Aff ecting the Cooperation Between Sales and Marketing in Pharmaceutical and Non-Pharmaceutical Manufacturing Firms," Tržište/Market, Faculty of Economics and Business, University of Zagreb, vol. 31(2), pages 227-247.
    7. Livio Garattini & Anna Padula, 2020. "HTA for pharmaceuticals in Europe: will the mountain deliver a mouse?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(1), pages 1-5, February.
    8. Rickard, Emily & Ozieranski, Piotr & Mulinari, Shai, 2019. "Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK," Health Policy, Elsevier, vol. 123(12), pages 1244-1250.
    9. Livio Garattini & Anna Padula & Nicholas Freemantle, 2021. "Pricing vaccines and drugs in Europe: worth differentiating?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(9), pages 1345-1348, December.
    10. Moriarty, Frank & Larkin, James & Fahey, Tom, 2021. "Payments reported by the pharmaceutical industry in Ireland from 2015 to 2019: An observational study," Health Policy, Elsevier, vol. 125(10), pages 1297-1304.
    11. Livio Garattini & Anna Padula, 2020. "Defensive medicine in Europe: a ‘full circle’?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(4), pages 477-482, June.
    12. Mulinari, Shai & Martinon, Luc & Jachiet, Pierre-Alain & Ozieranski, Piotr, 2021. "Pharmaceutical industry self-regulation and non-transparency: country and company level analysis of payments to healthcare professionals in seven European countries," Health Policy, Elsevier, vol. 125(7), pages 915-922.
    13. Anju Murayama & Akihiko Ozaki & Hiroaki Saito & Toyoaki Sawano & Yuki Shimada & Kana Yamamoto & Yosuke Suzuki & Tetsuya Tanimoto, 2020. "Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan," PLOS ONE, Public Library of Science, vol. 15(10), pages 1-16, October.
    14. Sheryl Spithoff & Pamela Leece & Frank Sullivan & Nav Persaud & Peter Belesiotis & Liane Steiner, 2020. "Drivers of the opioid crisis: An appraisal of financial conflicts of interest in clinical practice guideline panels at the peak of opioid prescribing," PLOS ONE, Public Library of Science, vol. 15(1), pages 1-15, January.
    15. Livio Garattini & Anna Padula, 2018. "Pharmaceutical pricing conundrum: time to get rid of it?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(8), pages 1035-1038, November.
    16. Livio Garattini & Anna Padula, 2020. "Defensive medicine in Europe: a ‘full circle’?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(2), pages 165-170, March.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:eujhec:v:20:y:2019:i:5:d:10.1007_s10198-018-1028-5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.